| 中文名称 | 5-Amino-(3,4'-bipyridin)-6(1H)-one |
| 英文名称 | 5-Amino-(3,4'-bipyridin)-6(1H)-one |
| CAS号 | 60719-84-8 |
| 分子式 | C10H9N3O |
| 分子量 | 187.2 |
| EINECS号 | 262-390-0 |
| 熔点 | 294-297°C (dec.) |
| 沸点 | 321.94°C (rough estimate) |
| 密度 | 1.2025 (rough estimate) |
| 折射率 | 1.4830 (estimate) |
| 溶解度 | DMF:0.3mg/mL;二甲基亚砜:0.5mg/mL |
| 形态 | 晶体 |
| 酸度系数(pKa) | 12.05±0.10(Predicted) |
| 颜色 | DMF 晶体 |
| 水溶解性 | Insoluble in water or chloroform. Slightly soluble in acetic acid or DMF. Soluble in DMSO |
| 危险品标志 | T,Xn |
| 危险类别码 | 25-36/37/38-20/21/22 |
| 安全说明 | 28-45-36-26 |
| 危险品运输编号 | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS号 | DW2500000 |
| 海关编码 | 29333999 |
| 危险等级 | 6.1(b) |
| 包装类别 | III |
| 毒性 | LD50 orl-rat: 102 mg/kg NDADD8 1,259,83 |
Amrinone (Inamrinone) produced a dose-dependent inhibition of ADP-induced rat platelet aggregation in vitro as well as ex vivo in rats. The proliferation of human aortic smooth muscle cells in culture stimulated with FBS or PDGF was also inhibited by amrinone.
Amrinone (Inamrinone) is administered subcutaneously to rats at a dose of 10 mg/kg/day for 14 days, significant reduction of neointimal thickness was noted.